| ¿µ¹® | neoplasm | ÇÑ±Û | ½Å»ý¹° |
|---|---|---|---|
| ¼³¸í | »õ·Î »ý±ä ¹°ÁúÀ̶ó´Â ¶æÀÌ´Ù. À̰ÍÀº ´Ù¸¥ ¸»·Î ¡°Á¾¾ç(tumor)¡±À̶ó°íµµ ÇÏ´Â µ¥, ½ÇÁ¦·Î À̵éÀÇ ¸íÈ®ÇÑ ¶æÀº ¼·Î ´Ù¸£´Ù. Á¾¾çÀ̶ó´Â ¸»Àº ¡°±× Å©±â°¡ 1cm°¡ ³Ñ´Â ÀÏÁ¾ÀÇ È¤¡±À» ¸»ÇÏ´Â °ÍÀ¸·Î ÇǺΰú¿¡¼´Â À̺¸´Ù ÀÛÀº ȤÀ» ±¸ÁøÀ̶ó°í ÇÏ¿© ±¸º°ÇÏ¿© ºÎ¸¥´Ù. ÇÏÁö¸¸, À̰ÍÀº ¶ÇÇÑ ÇǺλӸ¸ ¾Æ´Ï¶ó ½Åü³» ¾îµð¿¡¼µç »ý±æ ¼ö ÀÖÀ¸¹Ç·Î ¸ðµÎ ÅëĪÇÏ¿© Á¾¾çÀ̶ó°í ºÎ¸¥´Ù. ÀÌ¿¡ ºñÇØ ¡°½Å»ý¹°¡±Àº ½Åü³» ¾ø´ø °ÍÀÌ »õ·Î »ý°Ü³µ´Ù´Â ¶æÀ¸·Î ºÙÀÎ ¸»ÀÌ´Ù. ±×·¯³ª, ÀÌ µÑÀÇ °ü°è¸¦ ¸íÈ®È÷ ±ÔÁ¤ÁþÁö ¾Ê°í ÀÖÀ¸¸ç ´ë°³ °°Àº ¶æÀ¸·Î È¥¿ëµÈ´Ù. ½Å»ý¹°¿¡´Â ¡°¾ç¼º(benign)¡±°ú ¡°¾Ç¼º(malignant)¡±ÀÌ ÀÖ´Ù. ÀÌ µÑÀÇ ±¸º°Àº ¿©·¯ °¡Áö ±âÁØ¿¡ µû¸£Áö¸¸, ¶§·Î´Â ±¸º°ÀÌ ¾î·Á¿ï ¶§µµ ÀÖ´Ù. ´ë°³ ¾ç¼ºÀº »ý¸í´ÜÃàÀ» Àß ÀÏÀ¸Å°Áö ¾Ê´Â °ÍÀ¸·Î Ä¡·áÈÄ¿¡ Àç¹ßµµ Àß ÇÏÁö ¾Ê´Â´Ù. ÀÌ¿¡ ºñÇØ ¾Ç¼ºÀº Àç¹ß»Ó¸¸ ¾Æ´Ï¶ó ´Ù¸¥ ±â°üÀ¸·Î ¿Å°Ü°¡¼ °°Àº º´º¯ÀÌ ¹ß»ýÇÏ´Â ¡°ÀüÀÌ(metastasis)¡±Çö»óµµ ÀϾÙ. µû¶ó¼ »ý¸íÀ» ´ÜÃà½ÃŰ´Â °æ¿ì°¡ ¸¹À¸¸ç, ´ë°³ Ä¡·á°¡ ¾î·Æ´Ù. |
||
| ¿µ¹® | Dilatation and Curettage(D & C) | ÇÑ±Û | Àڱñܾ¼ú, ÀڱøñÈ®Àå |
|---|---|---|---|
| ¼³¸í | ÀÚ±ÃÀ̶õ žư¡ ¼öÅÂµÇ¾î¼ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇÏ´Â °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ žƸ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇÏ´Â ÀڱøñÀ» È®Àå½ÃÄÑ¾ß ÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇÏ´Â ¹ý°ú ¼¼È÷ È®ÀåÀ» ½ÃµµÇÏ´Â 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ ÀÖ¾î¼ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼¼È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇÏ´Â ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃÊ·Î ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î õõÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼ ÀڱüÓÀÇ º´º¯À̳ª ÀÓ½ÅµÈ Å¾Ƹ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀÇ Ã¤Ãë ¹× Á¦°Å¸¦ À§Çؼµµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. ÀÌ´Â ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà ³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù. |
||
| ¿µ¹® | eye | ÇÑ±Û | ´«, ¾È±¸ |
|---|---|---|---|
| ¼³¸í | ´«È® ¾È¿¡ ¹ÚÇôÀÖ´Â °ø¸ð¾çÀÇ ½Ã°¢±â°üÀÌ´Ù. ¾È±¸´Â 3ÃþÀÇ ÇǸ·(°ø¸·)°ú °¢¸·, ¸Æ¶ô¸·, ¸Á¸·¿¡ ½Î¿© ÀÖ´Ù. °¢°¢ÀÇ ÇǸ·Àº ¸î °³ÀÇ ÃþÀ¸·Î ³ª´©¾îÁø´Ù. 3ÃþÀÇ ÇǸ· Áß¿¡´Â ºûÀ» ±¼ÀýÇÏ´Â ¸Åü[¹æ¼ö, ¼öÁ¤Ã¼, À¯¸®Ã¼¾×]ÀÌ ÀÖ´Ù. ¿ÜÃøÀÇ °ø¸·Àº ¹é»öÀÌ¸ç ¼¶À¯»ó Á¶Á÷ÀÌ´Ù. °ø¸·ºÎ¿¡¼´Â ½Ã°¢½Å°æ¼¶À¯°¡ äÆÇÀÇ ÀÛÀº±¸¸ÛÀ» ÅëÇØ¼ ¾È±¸³»·Î µé¾î°£´Ù. °ø¸·ÀÇ ³»Ãø Ç¥¸éÀº ¼¶¼¼ÇÑ °áÇÕÁ¶Á÷°ú °¥»öÆÇ¿¡ ÀÇÇØ¼ ¸Æ¶ô¸·°ú Á¢Çϰí ÀÖ´Ù. °¢¸·Àº 5ÃþÀ̸ç, ±× ³»ÃþÀº À帷À¸·Î¼ µ¥½º¸Þ¸·À̶ó ºÒ¸®°í ÀÖ´Ù. Æ÷µµ¸·Àº ÁÖ·Î Ç÷°ü°ú »ö¼Ò·Î µÇ¾î ÀÖ´Ù. ¾ÕºÎ´Â ¼öÁ¤Ã¼ÀÇ ÁÖº¯ºÎ·Î¼ ¼¶¸ðüµ¹±â¶ó ºÒ¸®´Â ÁÖ¸§ÀÇ ÇüÀ¸·Î ³¡³´Ù. ¸Á¸·Àº ÁÖ·Î ½Å°æÁ¶Á÷À¸·Î¼ Å©°Ô´Â ¼¼°³ÀÇ ÃþÀ¸·Î µÇ¾î ÀÖ´Ù. ¿ÜÃþ¸·Àº ½Å°æ¼¼Æ÷·Î µÇ¾î ÀÖ°í ±× Çü»ó¿¡ µû¶ó ¿ø»Ôü¿Í ¸·´ëü·Î ºÒ¸°´Ù. ȫä´Â Áß¾Ó¿¡ µ¿°øÀ» °®´Â ºÎºÐÀ¸·Î, À±»ó°ú ¹æ»ç»óÀÇ ÆòȰ±Ù¼¶À¯¸¦ °®°í ÀÖ´Ù. ȫäÀÇ »öÀº ¿©·¯ °¡ÁöÀ̸ç, ¼öÁ¤Ã¼ÀÇ ¾Õ ¹æ¼öÁß¿¡ À§Ä¡Çϰí ÀÖ´Ù. ¼¶¸ðüÀδë´Â ȫ並 µÑ·¯½Î°í ÀÖ´Â °í¸®¸ð¾çÀÇ °áÇÕ¼¶À¯ÀÌ´Ù. ¼¶À¯Ã¼±ÙÀº ȫäÀÇ ÁÖÀ§¸¦ µÑ·¯½Î°í, Á¶ÀýÇÒ ¶§´Â ¼öÁ¤Ã¼ÀÇ ÇüÀ» ¹Ù²Û´Ù. ¹æ¼ö´Â ÀüºÎÀÇ °¢¸·°ú ÈĺÎÀÇ ¼öÁ¤Ã¼ »çÀÌ¿¡ ÀÖ´Ù. À¯¸®Ã¼¾×Àº ¼öÁ¤Ã¼ ÈĺÎÀÇ °ø°£À» ä¿ì¸ç, Åõ¸íÇÑ Á©¸®»óÀÇ ¹°ÁúÀ̰í, À¯¸®Ã¼¸·¿¡ ½Î¿© ÀÖ´Ù. ¼öÁ¤Ã¼´Â À¯¸®Ã¼¾×°ú ¹æ¼öÀÇ »çÀÌ¿¡ ÀÖ´Â ¾çÂÊÀÌ º¼·ÏÇÑ Åõ¸íÇÑ ¹°Ã¼·Î, ź¼ºÇǸ·°ú ¼Ò´ëÀδ뿡 ÀÇÇØ¼ ¾Ë¸ÂÀº Àå¼Ò¿¡ ´Þ·Á ÀÖ´Ù. ´«ÀÇ µ¿¸ÆÀº ªÀº ¼¶¸ðüµ¿¸Æ, ±ä¼¶¸ðüµ¿¸Æ, Àü¼¶¸ðüµ¿¸Æ, ¸Á¸·Á߽ɵ¿¸Æ µîÀÌ´Ù. ½Å°æÀº ½Ã°¢½Å°æ, ±ä¼¶¸ðü½Å°æ, ªÀº ¼¶¸ðü ½Å°æµîÀÌ´Ù. |
||
| ¿µ¹® | pink eye | ÇÑ±Û | ºÐÈ«»ö´«, ÃæÇ÷¾È |
|---|---|---|---|
| ¼³¸í | ÃæÇ÷µÈ ´«À» ºÎ¸£´Â ¸»ÀÌ´Ù. ´ë°³ °á¸·¿°°ú °°Àº ¶æÀ¸·Î ¾²ÀδÙ. °á¸·Àº ´«À» ¹Û¿¡¼ °üÂûÇßÀ» ¶§ ´«µ¿ÀÚ¸¦ Á¦¿ÜÇÑ Èñ°Ô º¸ÀÌ´Â ºÎºÐÀ» ¸»ÇÑ´Ù. ¿©±â¿¡ ¿°ÁõÀÌ »ý±ä °ÍÀ» °á¸·¿°À̶ó Çϴµ¥ ´ë°³ ¹ÙÀÌ·¯½º°¨¿°¿¡ ÀÇÇÑ´Ù. Àü¿°ÀÌ Àß µÇ¸ç, ƯÈ÷ ¼ö¿µÀå ÀÌ¿ëÀÌ ¸¹Àº ¿©¸§¿¡ À¯ÇàÇÑ´Ù. ´ëÇ¥ÀûÀÎ °ÍÀ¸·Î ¾ÆÆú·Î´«º´, À¯Ç༺°¢°á¸·¿° µîÀÌ ÀÖ´Ù. Ư¡ÀûÀÎ Áõ»óÀº ÃæÇ÷µÈ ´«¸ð¾çÀ̸ç, Ä¡·á´Â Ưº°ÇÑ °ÍÀÌ ¾ø°í 2Â÷°¨¿°À» ¿¹¹æÇϰí ÀúÀý·Î ³ªÀ» ¶§±îÁö ±â´Ù·Á¾ß ÇÑ´Ù. ´ë°³ 2ÁÖÈÄ¸é ³´´Â´Ù. |
||
| ¿µ¹® | benign | ÇÑ±Û | ¾ç¼º |
|---|---|---|---|
| ¼³¸í | Ä¡À¯°¡ Àß µÇ´Â, Á¾¾çÀÇ °æ¿ì¿¡¼´Â ´Ù¸¥ Á¶Á÷À¸·Î ÆÛÁöÁö ¾Ê°í ±×ºÎºÐ¿¡¼ ¸Ó¹°·¯ ÀÖ´Â Á¾¾çÀ» ¸»ÇÑ´Ù. |
||
| PBN | paralytic brachial neuritis; peripheral benign neoplasm; polymyxin B sulfate, bacitracin, and neomyc... |
|---|---|
| CEA | Carcino-Embryonic Antigen [HP 1825-6] ; Oncofetal Antigens ; Glycopro... |
| CBN | cannabinol; central benign neoplasm; Commission on Biological Nomenclature |
| BPV | benign paroxysmal vertigo; benign positional vertigo; bioprosthetic valve; bovine papilloma virus |
| FMN | first malignant neoplasm; flavin mononucleotide; frontomaxillonasal [suture] |
| SMN | Second Malignant Neoplasm |
|---|---|
| EMDR | Eye Movement Desensitization and Reprocessing |
| BBD | Benign Breast Disease |
| BCECT | Benign Childhood Epilepsy with Centrotemporal Spike |
| adnexa | This Latin word (in the plural) is used in medicine in reference to appendages. For example, in gynecology the adnexa are the appendages of the uterus, namely the ovaries, Fallopian tubes and ligaments that hold the uterus in place. (12 Dec 1998) |
|---|---|
| adnexa oculi | The eyelids, with lashes and eyebrows, lacrimal apparatus, conjunctival sac, and extrinsic muscles of the eyeball. Synonym: organa oculi accessoria, accessory organs, accessory visual apparatus, adnexa oculi, appendages of eye. (05 Mar 2000) |
| adnexa uteri | The uterine appendages: the ovaries, uterine tubes, and ligaments of the uterus. (12 Dec 1998) |
| antibodies, neoplasm | Immunoglobulins induced by antigens specific for tumours other than the normally occurring histocompatibility antigens. (12 Dec 1998) |
| antigens, neoplasm | Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumour cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. (12 Dec 1998) |
| brain neoplasm | Neoplasms of the part of the central nervous system contained within the cranium. (12 Dec 1998) |
| genes, structural, neoplasm | DNA sequences that code for RNA and for the proteins required for the enzymatic and structural function of neoplastic cells. (12 Dec 1998) |
| mucinous cystic neoplasm of pancreas | <radiology> = macrocystic adenoma of pancreas, cystadenoma / cystadenocarcinoma, M:F = 1:9, 40-60 years of age, malignant or pre-malignant, large mass (mean 12 cm), multilocular cysts, thick septations, tail / body in 85% (unlike adenocarcinoma and microcystic adenoma), hypo-/avascular, Differential diagnosis: panc pseudocyst, ** Cf: microcystic adenoma (12 Dec 1998) |
| histoid neoplasm | Old term for a neoplasm characterised by a cytohistologic pattern that closely resembles the tissue from which the neoplastic cells are derived. (05 Mar 2000) |
| neoplasm | <oncology, pathology> New and abnormal growth of tissue, which may be benign or cancerous. (16 Dec 1997) |
| neoplasm circulating cells | Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumours. (12 Dec 1998) |
| neoplasm: gallium imaging | <radiology> Useful: Hodgkin disease and histiocytic form of NHL poor sensitivity below the diaphragm, Burkitt lymphoma: almost 100% sensitivity, hepatoma: 90% sensitivity, melanoma: 90% sensitivity, leukaemia possibly useful: NHL: good for large and mediastinal lesions, nodal metastases from seminoma and embryonal cell carcinoma: 87% sensitivity, non-small cell lung CA: 85% sensitive not useful: head and neck, GI (especially adenocarcinoma), breast, gynaecological, kiddie tumours see: gallium: indications (12 Dec 1998) |
| neoplasm invasiveness | Ability of neoplasms to infiltrate and actively destroy surrounding tissue. (12 Dec 1998) |
| neoplasm metastasis | The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. The ability to metastasize is characteristic of all malignant neoplasms. (12 Dec 1998) |
| neoplasm recurrence, local | The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|